IL17A and idiopathic pulmonary fibrosis: Thus, our study opens the door for further exploration of the effect of LCN2 on lung injury diseases, such as IPF, and the impact of IL-17 on that process to provide fundamental ideas for the diagnosis and treatment of IPF.